Phio Pharmaceuticals Corp (PHIO)

[Inoviorulez]

But management knows the value of the company they won't sell it for only $100 million.

Here is what my belief is. The company announced that it is working on a merger agreement. So therefore I think they will merge with another small cap biotechnology company.

The company I'm leaning towards is Foamix Pharmaceuticals (FOMX) because it is dermatology and also uses topical drug candidates to treat sever to moderate acne and Rosacea. It also has $108 million in cash.

Therefore the combined companies would be beneficial because they both work with topical gels, both dermatology companies, and it would bring more cash to the table along with cosmecueticals. It will be a merger like that, not an acquisition. I don't see the company selling itself for only $100 mil when management knows its worth at least $500 mil or more.